SG Americas Securities LLC Has $31.17 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

SG Americas Securities LLC lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8,337.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 369,542 shares of the medical device company’s stock after purchasing an additional 365,162 shares during the quarter. SG Americas Securities LLC owned approximately 0.18% of Cooper Companies worth $31,171,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of COO. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in Cooper Companies in the 4th quarter valued at $691,000. Entropy Technologies LP bought a new position in shares of Cooper Companies during the fourth quarter valued at $248,000. Apollon Wealth Management LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $200,000. Figure 8 Investment Strategies LLC bought a new stake in Cooper Companies during the 4th quarter worth approximately $1,360,000. Finally, Proficio Capital Partners LLC acquired a new stake in Cooper Companies during the 4th quarter valued at $95,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $71.97 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The firm has a market cap of $14.39 billion, a PE ratio of 36.91, a price-to-earnings-growth ratio of 2.25 and a beta of 0.98. The firm’s fifty day moving average is $78.17 and its 200-day moving average is $87.02.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business posted $0.85 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on COO shares. Robert W. Baird reduced their price objective on Cooper Companies from $107.00 to $97.00 and set an “outperform” rating on the stock in a research note on Friday, May 30th. Piper Sandler reiterated an “overweight” rating and set a $105.00 price target (down previously from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, May 22nd. Finally, Wall Street Zen lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $100.38.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.